跳转至内容
Merck
CN

LC/MS Analysis of Illicit Drugs and Metabolites on Ascentis® Express RP-Amide

LC/MS Analysis of Illicit Drugs and Metabolites on Ascentis® Express RP-Amide application for LC-MS

材料

相关产品

产品编号
说明
价格

Ascentis® Express RP-Amide, 2.7 μm HPLC Column

2.7 μm particle size, L × I.D. 10 cm × 2.1 mm

Benzoylecgonine solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

(±)-Methadone solution

1 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Cocaine solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Cocaethylene solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

EDDP perchlorate solution

1.0 mg/mL in methanol (as pyrolinium), ampule of 1 mL, certified reference material, Cerilliant®

Norfentanyl oxalate solution

1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

CONDITIONS

column

Ascentis Express RP-Amide, 10 cm x 2.1 mm I.D., 2.7 μm particles (53913-U)

mobile phase

10 mM ammonium formate in water:acetonitrile (75:25)

flow rate

0.2 mL/min

column temp.

35 °C

detector

ESI+, MRM (see Figure for transitions)

injection

2 μL

sample

each compound 200 ng/mL in mobile phase

说明

分析说明

These illicit drugs are routinely tested in drug screens for forensic and pre-employment. Their rapid separation was achieved on an Ascentis Express RP-Amide column. Cerilliant CRMs provide reliable quantification.

法律信息

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany